Back to Search
Start Over
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
- Source :
- Leukemia
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
- Subjects :
- Cancer Research
2019-20 coronavirus outbreak
Letter
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Siltuximab
chemistry.chemical_compound
Antineoplastic Agents, Immunological
Medical research
Humans
Medicine
Prospective Studies
Interleukin 8
Pentraxin-3
Ventilators, Mechanical
SARS-CoV-2
business.industry
Interleukin-8
Antibodies, Monoclonal
COVID-19
Correction
Hematology
COVID-19 Drug Treatment
Survival Rate
Serum Amyloid P-Component
C-Reactive Protein
Oncology
chemistry
Acute Disease
Immunology
Infectious diseases
business
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 35
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi.dedup.....b21d4a1b46d3dfaac05f3aea2b4ec1d1